Seladelpar lysine dihydrate MBX-8052
【化學(xué)名】Seladelpar lysine dihydrate
【原研】Cymabay Therapeutics Inc
【上市時(shí)間】2024年08月14日
【用途】用于治療硬化性膽管炎
【劑型/規(guī)格】口服膠囊劑，規(guī)格EQ 10MG BASE
Seladelpar lysine dihydrate MBX-8052
一、產(chǎn)品概述
Seladelpar lysine dihydrate是由Cymabay Therapeutics Inc研發(fā)的一種小分子藥物，是一種PPARδ激動(dòng)劑。該藥物于2024年08月14日獲FDA批準(zhǔn)，用于治療硬化性膽管炎。
二、主要產(chǎn)品
Description | Structural Formula | CAS No. | Category |
Seladelpar lysine dihydrate |  | 928821-40-3 | API |
ethyl 2-(4-mercapto-2-methylphenoxy)acetate |
| 343322-82-7 | intermediates |
(R)-2-((4-(trifluoromethyl)phenoxy)methyl)oxirane |
| 256372-58-4 | intermediates |
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.